Open Access

Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs


Cite

K Prso
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in BratislavaMartin, Slovakia
N Zidekova
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in BratislavaMartin, Slovakia
M Dohal
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in BratislavaMartin, Slovakia
I Porvaznik
Department of Clinical Microbiology, National Institute for Tuberculosis, Lung Diseases and Thoracic Surgery Vyšné Hágy, Slovakia
Faculty of Health, Catholic UniversityRužomberok, Slovakia
M Prso
Clinic of Children and Adolescents Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, and Martin University HospitalMartin
M Kertys
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in BratislavaMartin, Slovakia
J Mokry
Department of Pharmacology and Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in BratislavaMartin, Slovakia
eISSN:
1338-4139
Language:
English
Publication timeframe:
3 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Cardiology